Researchers at the Spanish National Research Council (CSIC) Institute for Advanced Chemistry of Catalonia (IQAC-CSIC) have discovered and synthesized a number of molecules that inhibit the effects of ...
Terremoto Biosciences has launched with $75 million in series A financing to discover small-molecule drugs using its lysine-targeted covalency technology. Terremoto says most drugs that bind to ...
Oral presentation to highlight updated Phase 1 monotherapy safety and efficacy data for TOS-358, a covalent PI3Ka inhibitor ...
Misbehaving proteins are behind many diseases. One way drugmakers incapacitate these bad actors is to deploy molecules that bind to them. But finding solid footholds on the proteins to block their ...
In nature, molecules often show a strong preference for partnering with other molecules that share the same chirality or handedness. A behavior that is quite evident in the phenomenon known as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results